期刊文献+

奥美拉唑联合呋喃唑酮根除幽门螺杆菌的疗效观察 被引量:5

Clinical effect of dual Therapy of omeprazol plus furazolidone for eradication of Helicobacter pylori
下载PDF
导出
摘要 目的幽门螺杆菌(Helicobacterpylori,Hp)是慢性胃炎、消化性溃疡的主要致病因素之一。本研究旨在通过对奥美拉唑(OME)和呋喃唑酮(FZ)联合用药的疗效观察以寻求一种有效、方便的疗法。方法病例选择:经胃镜检查确诊的慢性胃炎或十二指肠球部溃疡且Hp检测阳性的患者,经过纳入标准及排除标准的筛选而进入研究。分组治疗:病例随机分为三个治疗组,治疗组1(23人):OME20mgqd+FZ0.2gbid;治疗组2(25人):OME20mgqd+FZ0.2gtid;治疗组3(26人):OME20mgbid+FZ0.2gtid,疗程均为7天。其中十二指肠球部溃疡病人OME按各自剂量再服一周。停药四周后做13C-尿素呼气试验。结果74例患者进入研究。治疗组1有22人完成全疗程,根除率864%;治疗组2为18人,根除率833%;治疗组3为19人,根除率789%。治疗组2、3(FZ02gtid)与治疗组1(FZ02gbid)之间根除率的差异无显著意义,但不良反应发生率明显增加。结论本研究显示方案一不良反应发生率低,依从性好,疗效达到864%;依从性是影响根除率高低的重要因素;体外试验显示Hp对呋喃唑酮? Aim Helicobacter pylori(Hp) is one of the main pathogenic factors of chronic gastritis and peptic ulcer.This study is to evaluate the clinical effect of dual therapy of OME (omeprazol)plus FZ(furazolidone) and consequently to find an effective and convenient medication for eradication of Hp. Methods Patients: The Hp postitive patients with chronic gastritis or duodenal ulcer confirmed by gastroscopy were enrolled in this research according to the eligibility criteria. Intervention: Totally 74 patients were finally selected and randomly allocated into 3 groups.The 7-day medication for Group 1(23 cases )was OME 20 mg qd+FZ 0.2 g bid,Group 2(25 cases) OME 20 mg qd+FZ 0.2 tid and Group 3 (26 cases)OME 20 mg bid+FZ 0.2 tid.The patients with duodenal ulcer took OME for one more week.The 13C-urea breath test for Hp infection was performed 4 weeks after the end of intervention. Results There were finally 22 patients in Group 1 who completed the interventional protocol,18 in group 2,and 19 in group 3.Comparing with the eradication rate of 86.4% of Group 1, the eradication rates of Group 2 and 3(83.3% and 78.9% respectively)has no significant difference;however,the adverse-effect rates of the latter two(32.0% and 23.1%,respectively)were much higher than that of Group 1(8.7%).HZ]Conclusion It showed that the therapy of OME 20 mg qd+FZ 0.2 bid could achieve the Hp eradication rate of 86.4% with low adverse-effect rate and good compliance.It was also found that the compliance was important for the eradication of Hp.The Hp strains in this research were all sensitive for FZ.
出处 《胃肠病学和肝病学杂志》 CAS 1999年第2期120-123,共4页 Chinese Journal of Gastroenterology and Hepatology
关键词 幽门螺杆菌 奥美拉唑 呋喃唑酮 胃炎 消化性溃疡 elicobacter pylori,drug-therapy,omeprazole,furazolidone
  • 相关文献

参考文献2

二级参考文献2

共引文献89

同被引文献18

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部